An interim analysis of quality of life in patients with relapsing-remitting multiple sclerosis treated with delayed-release dimethyl fumarate

被引：0
|
作者：
Sarda, S. P. [6 ]
Kita, M. [1 ]
Fox, R. J. [2 ]
Gold, R. [3 ]
Giovannoni, G. [4 ]
Phillips, T. [5 ]
Okwuokenye, M. [6 ]
Kong, J. [6 ]
Zhang, R. [6 ]
Kurukulasuriya, N. C. [6 ]
Kappos, L. [7 ]
机构：
[1] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH USA
[3] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[4] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[5] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[6] Biogen Idec Inc, Cambridge, MA USA
[7] Univ Basel Hosp, Basel Neurol, CH-4031 Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P790
引用
收藏
页码：413 / 414
页数：2
相关论文
共 50 条
  • [41] Efficacy of delayed-release dimethyl fumarate for relapsing-remitting multiple sclerosis (RRMS) in "non-responders" to prior treatment with interferon beta
    Fernandez, O.
    Giovannoni, G.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Yang, M.
    Zhang, A.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 25 - 25
  • [42] Actual adherence to dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    de Sa, Joao
    Ferreira, Joao
    Macedo, Ana M.
    REVISTA DE NEUROLOGIA, 2023, 76 : S1 - S6
  • [43] Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis
    Muller, Jannis
    Schadelin, Sabine
    Lorscheider, Johannes
    Benkert, Pascal
    Hanni, Peter
    Schmid, Jurg
    Kuhle, Jens
    Derfuss, Tobias
    Granziera, Cristina
    Yaldizli, Ozgur
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (12) : 3809 - 3818
  • [44] Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis
    Lorscheider, Johannes
    Benkert, Pascal
    Lienert, Carmen
    Haenni, Peter
    Derfuss, Tobias
    Kuhle, Jens
    Kappos, Ludwig
    Yaldizli, Oezguer
    JOURNAL OF NEUROLOGY, 2021, 268 (03) : 941 - 949
  • [45] Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis
    Mueller, J.
    Schaedelin, S.
    Benkert, P.
    Haenni, P.
    Schmid, J.
    Derfuss, T.
    Kuhle, J.
    Yaldizli, O.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 676 - 676
  • [46] A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries
    Takahiko Saida
    Takashi Yamamura
    Takayuki Kondo
    Jang Yun
    Minhua Yang
    Jie Li
    Lalitha Mahadavan
    Bing Zhu
    Sarah I. Sheikh
    BMC Neurology, 19
  • [47] Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE)
    Gold, Ralf
    Schlegel, Eugen
    Elias-Hamp, Birte
    Albert, Christian
    Schmidt, Stephan
    Tackenberg, Bjoern
    Xiao, James
    Schaak, Tom
    Salmen, Hans Christian
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [48] Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE
    Gold, Ralf
    Arnold, Douglas L.
    Bar-Or, Amit
    Fox, Robert J.
    Kappos, Ludwig
    Chen, Chongshu
    Parks, Becky
    Miller, Catherine
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [49] A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries
    Saida, Takahiko
    Yamamura, Takashi
    Kondo, Takayuki
    Yun, Jang
    Yang, Minhua
    Li, Jie
    Mahadavan, Lalitha
    Zhu, Bing
    Sheikh, Sarah I.
    BMC NEUROLOGY, 2019, 19 (1)
  • [50] Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies
    Havrdova, E.
    Giovannoni, G.
    Gold, R.
    Fox, R. J.
    Kappos, L.
    Phillips, J. Theodore
    Okwuokenye, M.
    Marantz, J. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (05) : 726 - 733
12345